Anne Moscona Selected Research

Musculoskeletal Diseases (Musculoskeletal Disease)

1/2020

Chikungunya infection: de-linking replication from symptomatology reveals the central role of muscle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Moscona Research Topics

Disease

37	Infections 10/2022 - 07/2005
18	Paramyxoviridae Infections (Parainfluenza) 10/2023 - 07/2005
9	COVID-19 01/2024 - 07/2020
8	Measles 10/2023 - 02/2015
8	Virus Diseases (Viral Diseases) 01/2022 - 05/2009
8	Human Influenza (Influenza) 12/2011 - 08/2004
4	Pneumonia (Pneumonitis) 01/2020 - 06/2008
4	Bronchiolitis 01/2020 - 10/2006
3	Subacute Sclerosing Panencephalitis (SSPE) 01/2021 - 01/2019
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020 - 07/2005
3	Croup 01/2020 - 01/2012
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 11/2014
2	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 01/2019
2	Respiratory Syncytial Virus Infections 01/2020 - 01/2019
2	Henipavirus Infections 01/2018 - 10/2010
1	Thrombosis (Thrombus) 01/2022
1	Persistent Infection 12/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2012
1	Central Nervous System Diseases (CNS Diseases) 07/2010
1	Vesicular Stomatitis 11/2009
1	Malaria 05/2009
1	Otitis Media 06/2008
1	Influenza in Birds (Avian Flu) 01/2008

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2009
21	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2008
13	Peptides (Polypeptides)IBA 10/2022 - 07/2010
13	Glycoproteins (Glycoprotein)IBA 01/2021 - 05/2009
12	VaccinesIBA 01/2024 - 01/2012
10	Neuraminidase (Sialidase)IBA 10/2023 - 09/2005
9	LipopeptidesIBA 10/2022 - 01/2018
7	Carrier Proteins (Binding Protein)IBA 10/2023 - 10/2013
7	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2012
5	Hemagglutinins (Hemagglutinin)IBA 10/2023 - 12/2011
5	CholesterolIBA 12/2013 - 07/2010
5	Oseltamivir (Tamiflu)FDA Link 03/2009 - 08/2004
3	AntibodiesIBA 01/2021 - 07/2020
3	Zanamivir (Relenza)FDA Link 01/2008 - 02/2006
2	AerosolsIBA 10/2022 - 06/2022
2	Neutralizing AntibodiesIBA 01/2022 - 01/2021
2	InterferonsIBA 10/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 07/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 07/2020
2	Amino Acids FDA Link 01/2021 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2021 - 07/2020
2	sialic acid receptorIBA 10/2013 - 12/2012
1	Monoclonal AntibodiesIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	LipidsIBA 08/2021
1	Single-Chain AntibodiesIBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	HN ProteinIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	Protein CIBA 10/2018
1	peptide AIBA 12/2011
1	oplunofuspIBA 07/2010
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2010
1	GliotoxinIBA 11/2009
1	Viral HemagglutininsIBA 07/2009
1	Chloroquine (Aralen)FDA LinkGeneric 05/2009
1	Cell Surface ReceptorsIBA 07/2005
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 07/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2005
2	Intranasal Administration 01/2021 - 11/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2020